Do we need more iron-chelating drugs?

被引：16

作者：

Kontoghiorghes, GJ ^{[1
]}

机构：

[1] Postgrad Res Inst Sci Technol Environm & Med, CY-3021 Limassol, Cyprus

来源：

LANCET | 2003年 / 362卷 / 9382期

关键词：

D O I：

10.1016/S0140-6736(03)14085-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：495 / 496

页数：2

共 5 条

[1] LONG-TERM ASSESSMENT OF EFFICACY AND SAFETY OF L1, AN ORAL IRON CHELATOR, IN TRANSFUSION DEPENDENT THALASSEMIA - INDIAN TRIAL [J].

AGARWAL, MB ;

GUPTE, SS ;

VISWANATHAN, C ;

VASANDANI, D ;

RAMANATHAN, J ;

DESAI, N ;

PUNIYANI, RR ;

CHHABLANI, AT .

BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (02) :460-466

[2] Benefits and risks of deferiprone in iron overload in thalassaemia and other conditions - Comparison of epidemiological and therapeutic aspects with deferoxamine [J].

Kowoghiorghes, GJ ;

Neocleous, K ;

Koinagou, A .

DRUG SAFETY, 2003, 26 (08) :553-584

[3] Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia:: a randomised, double-blind, placebo-controlled, dose-escalation trial [J].

Nisbet-Brown, E ;

Olivieri, NF ;

Giardina, PJ ;

Grady, RW ;

Neufeld, EJ ;

Séchaud, R ;

Krebs-Brown, AJ ;

Anderson, JR ;

Alberti, D ;

Sizer, KC ;

Nathan, DG .

LANCET, 2003, 361 (9369) :1597-1602

[4] COMPARISON OF ORAL IRON CHELATOR L1 AND DESFERRIOXAMINE IN IRON-LOADED PATIENTS [J].

OLIVIERI, NF ;

KOREN, G ;

HERMANN, C ;

BENTUR, Y ;

CHUNG, D ;

KLEIN, J ;

STLOUIS, P ;

FREEDMAN, MH ;

MCCLELLAND, RA ;

TEMPLETON, DM .

LANCET, 1990, 336 (8726) :1275-1279

[5] 8-HYDROXYQUINOLINE - CHRONIC TOXICITY AND INHIBITORY EFFECT ON CARCINOGENICITY OF N-2-FLUORENYLACETAMIDE [J].

YAMAMOTO, RS ;

WILLIAMS, GM ;

FRANKEL, HH ;

WEISBURGER, JH .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 1971, 19 (04) :687-+

← 1 →